Translate page

Flagge RusslandSeptember 2020 - Please join us for an iCMLf Conversation on COVID-19 and CML in Russian. On September 29th Dr Elza Lomaia and her collagues from the Russian Federation will be sharing their experience with CML management during the pandemic.

CML management during the COVID-19 pandemic
– perspectives from Russia (in Russian)

September 29th at 14.00 Moscau Time / 13.00 Central European Time

  • Dr Elza Lomaia, Almazov National Medical Research Centre, Saint-Petersburg (Russian Federation)
  • Dr Jurii Osipov, Almazov National Medical Research Centre, Saint-Petersburg (Russian Federation)
  • Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow (Russian Federation)

What will be discussed during the webinar?

  • CML treatment recommendations for people without COVID-19 including therapy initiation/therapy switch/ monitoring/ new trials / drugs for CML -  Dr Elza Lomaia (10 mins)
  • The optimal strategy for prevention of COVID-19 and management of COVID-19 patients -  Dr Yurii Osipov (10 mins)
  • Recommendations for treating people with CML and COVID-19 including therapy initiation/therapy switch/therapy stopping/any interaction with COVI-19 treatment/TFR
    - Dr Ekaterina Chelysheva (10 mins)
  • Summary - Dr Elza Lomaia (5 mins)

At what time does the webinar take place in my time zone?

The webinar will be held from

  • 14.00 – 14.45 Moscow Time
  • 13.00 – 13.45 Central European Time

Save to your calendar:

How can I dial into the webinar?
Please join this meeting from your computer, tablet or smartphone via the link below:
Meeting-ID: 838 3632 9370

Can I ask questions during the webinars?

An important part of the conversation will be questions from the audience. You can submit your questions via chat during the webinar and the experts will answer as many as possible during the Q&A session.

I won’t be able to attend. Can I watch the webinars at a later time?

All webinars will be made available on the iCMLf website after the event.

If you have any questions or need assistance, please email to